IMC_驚喜任你抓
 
The Peptide Revolution: Past, Present, and Future

The Peptide Revolution: Past, Present, and Future

PEPTIDE REVOLUTION

作者：
Brigham Buhler ; Lee Rosebush
出版社：
Maha Books
出版日期：
2026/08/03
刷誠品聯名卡，天天享最高7%回饋
大量採購團購專區
9
760684
訂單自國外空運，約14-21個工作天(不含例假日)到貨後依序出貨。為縮短等待，建議將此商品和其他商品分開下單。
查詢門市庫存

內容簡介

The Molecules Everyone Is Talking About--Finally Explained

You've probably seen the word "peptides" everywhere lately--wellness podcasts, weight-loss headlines, gym locker rooms, your cousin's Instagram stories. But what are they, really? And should you care?

The Peptide Revolution cuts through the noise. Written by a leading wellness CEO and a pharmacist-attorney who helped fight the government over peptide access, it makes a simple case: peptides aren't a trendy fad--they're biological text messages your body has been sending for over a century. Insulin, the drug that turned Type 1 diabetes from a death sentence into a manageable condition? A peptide. The GLP-1 shots reshaping America's relationship with food and obesity? Also peptides.

The book covers the full landscape: how these molecules actually work, why "FDA-approved" doesn't mean safe and "unapproved" doesn't mean dangerous, and how to tell a legitimate compounding pharmacy from a sketchy research-chemical website with a suspiciously professional logo.

But underneath the science is a bigger fight: who gets to decide what you can put in your own body. As regulators and institutions move to restrict access to compounded peptides, millions of patients are being cut off from therapies they understand and can use responsibly. The authors argue that access isn't a fringe convenience--it's the front line of medical freedom. And restricting legitimate access doesn't make people safer; it pushes them toward the gray market, stripping away the very oversight that protects them.

Most importantly, it's a book about you and your body. It asks the hard questions--who weighs the risks, who gets to say no, and what patients lose when those decisions are made for them--and hands readers the tools to advocate for themselves and have smarter conversations with their doctors.

Equal parts science primer, patient empowerment guide, and call to defend medical freedom, The Peptide Revolution is for anyone who's ever thought: I just want to feel better--and I want the right to understand and choose what I'm putting in my body.
展開看更多

作者介紹

Brigham Buhler is a healthcare entrepreneur, founder of Ways2Well, and owner of ReviveRx Pharmacy. A former pharmaceutical and medical device insider, Buhler has spent more than two decades working across the systems that shape American healthcare--from pharmacy access and clinical diagnostics to preventative care, hormone optimization, and regenerative medicine. His work focuses on exposing the incentives that keep patients sick while building practical alternatives rooted in transparency, clinician guidance, and proactive health optimization. Through Ways2Well and ReviveRx, Buhler is helping advance a model of care that prioritizes patient access, better data, legitimate pharmacy oversight, and healthspan over disease management.

Lee H. Rosebush, Pharm.D, JD, MBA, MS, is chairman of the Outsourcing Facilities Association (OFA), which represents FDA-registered 503B outsourcing facilities nationwide. A pharmacist and attorney with experience spanning hospital, retail, and regulatory settings, he advises on compounding policy, patient access, and the legal and operational issues shaping the industry. He has been active in state and national compounding policy efforts, including support for Colorado's HB26-1262, Patient Access to Compounded Medical Items. Through legislative testimony and public advocacy, Rosebush has helped clarify issues affecting access to compounded medications and the alignment of state requirements with federal 503B standards. He also speaks and writes frequently on FDA compounding regulation, the Drug Quality and Security Act (DQSA), drug shortages, and broader pharmacy policy issues. Drawing on prior regulatory experience in the FDA's Office of Orphan Products Development, he provides strategic counsel on compliance, advocacy, and emerging industry challenges. His work bridges legal, regulatory, and policy considerations for stakeholders navigating a complex and evolving compounding landscape.

規格

誠品貨碼 /
ISBN13 / 9781631441288
ISBN10 /
EAN貨碼 / 9781631441288
裝訂 / H:精裝
頁數 / 160
重量(g) / 204.1
語言 / 3:英文
級別 / N:無
尺寸 / 17.8X13.2X1.8CM

退貨說明

退貨須知：

  1. 依照消費者保護法的規定，您享有商品貨到次日起七天猶豫期(含例假日)的權益(請注意！猶豫期非試用期)，辦理退貨之商品必須是全新狀態(不得有刮傷、破損、受潮)且需完整(包含全部商品、配件、原廠內外包裝、贈品及所有附隨文件或資料的完整性等)。
  2. 請您以送貨廠商使用之包裝紙箱將退貨商品包裝妥當，若原紙箱已遺失，請另使用其他紙箱包覆於商品原廠包裝之外，切勿直接於原廠包裝上黏貼紙張或書寫文字。若原廠包裝損毀將可能被認定為已逾越檢查商品之必要程度，本公司得依毀損程度扣除回復原狀必要費用(整新費)後退費；請您先確認商品正確、外觀可接受，再行拆封，以免影響您的權利；若為產品瑕疵，本公司接受退貨。

依「通訊交易解除權合理例外情事適用準則」，下列商品不適用七日猶豫期，除產品本身有瑕疵外，不接受退貨：

  1. 易於腐敗、保存期限較短或解約時即將逾期。(如:生鮮蔬果、乳製品、冷凍冷藏食材、蛋糕)
  2. 依消費者要求所為之客製化給付。(如:客製印章、鋼筆刻字)
  3. 報紙、期刊或雜誌。
  4. 經消費者拆封之影音商品或電腦軟體。
  5. 非以有形媒介提供之數位內容或一經提供即為完成之線上服務，經消費者事先同意始提供。(如:電子書)
  6. 已拆封之個人衛生用品。(如:內衣褲、襪類、褲襪、刮鬍刀、除毛刀等貼身用品)
  7. 國際航空客運服務。

若您退貨時有下列情形，可能被認定已逾越檢查商品之必要程度而須負擔為回復原狀必要費用(整新費)，或影響您的退貨權利，請您在拆封前決定是否要退貨：

  1. 以數位或電磁紀錄形式儲存或著作權相關之商品(包含但不限於CD、VCD、DVD、電腦軟體等) 包裝已拆封者(除運送用之包裝以外)。
  2. 耗材(包含但不限於墨水匣、碳粉匣、紙張、筆類墨水、清潔劑補充包等)之商品包裝已拆封者(除運送用之包裝以外)。
  3. 衣飾鞋類/寢具/織品(包含但不限於衣褲、鞋子、襪子、泳裝、床單、被套、填充玩具)或之商品缺件(含購買商品、附件、內外包裝、贈品等)或經剪標或下水或商品有不可回復之髒污或磨損痕跡。
  4. 食品、美容/保養用品、內衣褲等消耗性或個人衛生用品、商品銷售頁面上特別載明之商品已拆封者(除運送用之包裝外一切包裝、包括但不限於瓶蓋、封口、封膜等接觸商品內容之包裝部分)或已非全新狀態(外觀有刮傷、破損、受潮等)與包裝不完整(缺少商品、附件、原廠外盒、保護袋、配件紙箱、保麗龍、隨貨文件、贈品等)。
  5. 家電、3C、畫作、電子閱讀器等商品，除商品本身有瑕疵外，退回之商品已拆封(除運送用之包裝外一切包裝、包括但不限於封膜等接觸商品內容之包裝部分、移除封條、拆除吊牌、拆除貼膠或標籤等情形)或已非全新狀態(外觀有刮傷、破損、受潮等)與包裝不完整(缺少商品、附件、原廠外盒、保護袋、配件紙箱、保麗龍、隨貨文件、贈品等)。
  6. 退貨程序請參閱【客服專區→常見問題→誠品線上退貨退款】之說明。
付款/配送